Furthermore, using mice harboring EC-specific transgene of calpastatin, the same authors observed a weakening of tumor angiogenesis in a Lewis lung carcinoma allograft transplantation model, potentially mediated by the inhibition of VEGF-C production through calpain/SOCS3/STAT3 (53). The gene discussed is STAT3; the disease is neoplasm.